{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:37:23Z","timestamp":1791859043244,"version":"4.3.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T00:00:00Z","timestamp":1480896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T00:00:00Z","timestamp":1480896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertensive rats with chronic kidney disease (CKD) exhibit enhanced gamma-aminobutyric acid (GABA)<jats:sub>B<\/jats:sub> receptor function and regulation within the nucleus tractus solitarii (NTS). For CKD with hypertension, renal denervation (RD) interrupts the afferent renal sympathetic nerves, which are connecting to the NTS. The objective of the present study was to investigate how RD improves CKD-induced hypertension. Rats underwent 5\/6 nephrectomy for 8 weeks, which induced CKD and hypertension. RD was induced by applying phenol to surround the renal artery in CKD. RD improved blood pressure (BP) by lowering sympathetic nerve activity and markedly restored the baroreflex response in CKD. The GABA<jats:sub>B<\/jats:sub> receptor expression was increased in the NTS of CKD; moreover, the central GABA levels were reduced in the cerebrospinal fluid, and the peripheral GABA levels were increased in the serum. RD restored the glutamic acid decarboxylase activity in the NTS in CKD, similar to the effect observed for central treatment with baclofen, and the systemic administration of gabapentin reduced BP. RD slightly improved renal function and cardiac load in CKD. RD may improve CKD-induced hypertension by modulating the baroreflex response, improving GABA system dysfunction and preventing the development and reducing the severity of cardiorenal syndrome type 4 in CKD rats.<\/jats:p>","DOI":"10.1038\/srep38447","type":"journal-article","created":{"date-parts":[[2016,12,5]],"date-time":"2016-12-05T10:30:56Z","timestamp":1480933856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Renal Denervation Improves the Baroreflex and GABA System in Chronic Kidney Disease-induced Hypertension"],"prefix":"10.1038","volume":"6","author":[{"given":"Hsin-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yu","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Jung","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Ming","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Chang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo-Ching","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Jiunn","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,5]]},"reference":[{"key":"BFsrep38447_CR1","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/j.ajkd.2007.12.012","volume":"51","author":"MV Rao","year":"2008","unstructured":"Rao, M. V., Qiu, Y., Wang, C. & Bakris, G. Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999\u20132004. Am J Kidney Dis 51, S30\u201337, doi: 10.1053\/j.ajkd.2007.12.012 (2008).","journal-title":"Am J Kidney Dis"},{"key":"BFsrep38447_CR2","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","volume":"108","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak, M. J. et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108, 2154\u20132169, doi: 10.1161\/01.CIR.0000095676.90936.80 (2003).","journal-title":"Circulation"},{"key":"BFsrep38447_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ki.2015.58","volume":"88","author":"S Anand","year":"2015","unstructured":"Anand, S. et al. Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease. Kidney Int 88, 178\u2013185, doi: 10.1038\/ki.2015.58 (2015).","journal-title":"Kidney Int"},{"key":"BFsrep38447_CR4","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian, A. V. et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 2560\u20132572, doi: 10.1001\/jama.289.19.2560 (2003).","journal-title":"JAMA"},{"key":"BFsrep38447_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneph.2010.154","volume":"7","author":"S Udani","year":"2011","unstructured":"Udani, S., Lazich, I. & Bakris, G. L. Epidemiology of hypertensive kidney disease. Nat Rev Nephrol 7, 11\u201321, doi: 10.1038\/nrneph.2010.154 (2011).","journal-title":"Nat Rev Nephrol"},{"key":"BFsrep38447_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nrneph.2014.59","volume":"10","author":"R Veelken","year":"2014","unstructured":"Veelken, R. & Schmieder, R. E. Renal denervation-implications for chronic kidney disease. Nat Rev Nephrol 10, 305\u2013313, doi: 10.1038\/nrneph.2014.59 (2014).","journal-title":"Nat Rev Nephrol"},{"key":"BFsrep38447_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ki.1997.103","volume":"51","author":"S Ye","year":"1997","unstructured":"Ye, S., Ozgur, B. & Campese, V. M. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 51, 722\u2013727 (1997).","journal-title":"Kidney Int"},{"key":"BFsrep38447_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0006-8993(98)00950-0","volume":"812","author":"ML Weiss","year":"1998","unstructured":"Weiss, M. L. & Chowdhury, S. I. The renal afferent pathways in the rat: a pseudorabies virus study. Brain Res 812, 227\u2013241 (1998).","journal-title":"Brain Res"},{"key":"BFsrep38447_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/HYPERTENSIONAHA.113.02272","volume":"63","author":"TC Yeh","year":"2014","unstructured":"Yeh, T. C. et al. Caffeine intake improves fructose-induced hypertension and insulin resistance by enhancing central insulin signaling. Hypertension 63, 535\u2013541, doi: 10.1161\/HYPERTENSIONAHA.113.02272 (2014).","journal-title":"Hypertension"},{"key":"BFsrep38447_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1161\/01.HYP.7.2.262","volume":"7","author":"AF Sved","year":"1985","unstructured":"Sved, A. F., Imaizumi, T., Talman, W. T. & Reis, D. J. Vasopressin contributes to hypertension caused by nucleus tractus solitarius lesions. Hypertension 7, 262\u2013267 (1985).","journal-title":"Hypertension"},{"key":"BFsrep38447_CR11","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1161\/01.HYP.33.1.530","volume":"33","author":"VR Durgam","year":"1999","unstructured":"Durgam, V. R., Vitela, M. & Mifflin, S. W. Enhanced gamma-aminobutyric acid-B receptor agonist responses and mRNA within the nucleus of the solitary tract in hypertension. Hypertension 33, 530\u2013536 (1999).","journal-title":"Hypertension"},{"key":"BFsrep38447_CR12","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1053\/ajkd.2001.27419","volume":"38","author":"MJ Smogorzewski","year":"2001","unstructured":"Smogorzewski, M. J. Central nervous dysfunction in uremia. Am J Kidney Dis 38, S122\u2013128 (2001).","journal-title":"Am J Kidney Dis"},{"key":"BFsrep38447_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/01.HYP.37.2.619","volume":"37","author":"M Vitela","year":"2001","unstructured":"Vitela, M. & Mifflin, S. W. gamma-Aminobutyric acid(B) receptor-mediated responses in the nucleus tractus solitarius are altered in acute and chronic hypertension. Hypertension 37, 619\u2013622 (2001).","journal-title":"Hypertension"},{"key":"BFsrep38447_CR14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/HYPERTENSIONAHA.109.145151","volume":"55","author":"W Zhang","year":"2010","unstructured":"Zhang, W. & Mifflin, S. Chronic hypertension enhances presynaptic inhibition by baclofen in the nucleus of the solitary tract. Hypertension 55, 481\u2013486, doi: 10.1161\/HYPERTENSIONAHA.109.145151 (2010).","journal-title":"Hypertension"},{"key":"BFsrep38447_CR15","doi-asserted-by":"publisher","first-page":"R292","DOI":"10.1152\/ajpregu.00194.2011","volume":"302","author":"FL Martin","year":"2012","unstructured":"Martin, F. L. et al. Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection. Am J Physiol Regul Integr Comp Physiol 302, R292\u2013299, doi: 10.1152\/ajpregu.00194.2011 (2012).","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"BFsrep38447_CR16","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco, C., Haapio, M., House, A. A., Anavekar, N. & Bellomo, R. Cardiorenal syndrome. J Am Coll Cardiol 52, 1527\u20131539, doi: 10.1016\/j.jacc.2008.07.051 (2008).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep38447_CR17","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","volume":"59","author":"MC Brandt","year":"2012","unstructured":"Brandt, M. C. et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 59, 901\u2013909, doi: 10.1016\/j.jacc.2011.11.034 (2012).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep38447_CR18","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.116.303603","volume":"116","author":"S Oparil","year":"2015","unstructured":"Oparil, S. & Schmieder, R. E. New approaches in the treatment of hypertension. Circ Res 116, 1074\u20131095, doi: 10.1161\/CIRCRESAHA.116.303603 (2015).","journal-title":"Circ Res"},{"key":"BFsrep38447_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.110.971580","volume":"123","author":"H Krum","year":"2011","unstructured":"Krum, H. et al. Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 123, 209\u2013215, doi: 10.1161\/CIRCULATIONAHA.110.971580 (2011).","journal-title":"Circulation"},{"key":"BFsrep38447_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/01.RES.57.5.676","volume":"57","author":"JE Faber","year":"1985","unstructured":"Faber, J. E. & Brody, M. J. Afferent renal nerve-dependent hypertension following acute renal artery stenosis in the conscious rat. Circ Res 57, 676\u2013688 (1985).","journal-title":"Circ Res"},{"key":"BFsrep38447_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/HYPERTENSIONAHA.109.140665","volume":"55","author":"K Heusser","year":"2010","unstructured":"Heusser, K. et al. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension 55, 619\u2013626, doi: 10.1161\/HYPERTENSIONAHA.109.140665 (2010).","journal-title":"Hypertension"},{"key":"BFsrep38447_CR22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","volume":"57","author":"HTNI Symplicity","year":"2011","unstructured":"Symplicity, H. T. N. I. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension 57, 911\u2013917, doi: 10.1161\/HYPERTENSIONAHA.110.163014 (2011).","journal-title":"Hypertension"},{"key":"BFsrep38447_CR23","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1111\/j.1471-4159.1985.tb05521.x","volume":"45","author":"TL Perry","year":"1985","unstructured":"Perry, T. L. et al. Neurochemical abnormalities in brains of renal failure patients treated by repeated hemodialysis. J Neurochem 45, 1043\u20131048 (1985).","journal-title":"J Neurochem"},{"key":"BFsrep38447_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1079\/BJN20041221","volume":"92","author":"K Hayakawa","year":"2004","unstructured":"Hayakawa, K. et al. Effect of a gamma-aminobutyric acid-enriched dairy product on the blood pressure of spontaneously hypertensive and normotensive Wistar-Kyoto rats. Br J Nutr 92, 411\u2013417 (2004).","journal-title":"Br J Nutr"},{"key":"BFsrep38447_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ejphar.2005.09.020","volume":"524","author":"K Hayakawa","year":"2005","unstructured":"Hayakawa, K., Kimura, M. & Yamori, Y. Role of the renal nerves in gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur J Pharmacol 524, 120\u2013125, doi: 10.1016\/j.ejphar.2005.09.020 (2005).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep38447_CR26","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1161\/CIRCRESAHA.113.301814","volume":"113","author":"YB Kim","year":"2013","unstructured":"Kim, Y. B. et al. GABAergic excitation of vasopressin neurons: possible mechanism underlying sodium-dependent hypertension. Circ Res 113, 1296\u20131307, doi: 10.1161\/CIRCRESAHA.113.301814 (2013).","journal-title":"Circ Res"},{"key":"BFsrep38447_CR27","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1681\/ASN.V1261218","volume":"12","author":"F Schaefer","year":"2001","unstructured":"Schaefer, F. et al. Experimental uremia affects hypothalamic amino acid neurotransmitter milieu. J Am Soc Nephrol 12, 1218\u20131227 (2001).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep38447_CR28","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1113\/jphysiol.2004.076885","volume":"562","author":"CY Chen","year":"2005","unstructured":"Chen, C. Y. & Bonham, A. C. Glutamate suppresses GABA release via presynaptic metabotropic glutamate receptors at baroreceptor neurones in rats. J Physiol 562, 535\u2013551, doi: 10.1113\/jphysiol.2004.076885 (2005).","journal-title":"J Physiol"},{"key":"BFsrep38447_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.302522","volume":"115","author":"M Bohm","year":"2014","unstructured":"Bohm, M., Linz, D., Ukena, C., Esler, M. & Mahfoud, F. Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond? Circ Res 115, 400\u2013409, doi: 10.1161\/CIRCRESAHA.115.302522 (2014).","journal-title":"Circ Res"},{"key":"BFsrep38447_CR30","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","volume":"71","author":"CU Correll","year":"2014","unstructured":"Correll, C. U. et al. Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study. JAMA Psychiatry 71, 1350\u20131363, doi: 10.1001\/jamapsychiatry.2014.1314 (2014).","journal-title":"JAMA Psychiatry"},{"key":"BFsrep38447_CR31","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1081\/JDI-120039823","volume":"26","author":"H Micozkadioglu","year":"2004","unstructured":"Micozkadioglu, H. et al. Gabapentin versus levodopa for the treatment of Restless Legs Syndrome in hemodialysis patients: an open-label study. Ren Fail 26, 393\u2013397 (2004).","journal-title":"Ren Fail"},{"key":"BFsrep38447_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.smrv.2014.07.006","volume":"21","author":"GK Sakkas","year":"2015","unstructured":"Sakkas, G. K. et al. Current trends in the management of uremic restless legs syndrome: a systematic review on aspects related to quality of life, cardiovascular mortality and survival. Sleep Med Rev 21, 39\u201349, doi: 10.1016\/j.smrv.2014.07.006 (2015).","journal-title":"Sleep Med Rev"},{"key":"BFsrep38447_CR33","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","volume":"327","author":"RL Converse Jr.","year":"1992","unstructured":"Converse, R. L. Jr. et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 327, 1912\u20131918, doi: 10.1056\/NEJM199212313272704 (1992).","journal-title":"N Engl J Med"},{"key":"BFsrep38447_CR34","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/j.jacc.2013.10.073","volume":"63","author":"SH Schirmer","year":"2014","unstructured":"Schirmer, S. H. et al. Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction. J Am Coll Cardiol 63, 1916\u20131923, doi: 10.1016\/j.jacc.2013.10.073 (2014).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep38447_CR35","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1093\/eurheartj\/ehu093","volume":"35","author":"F Mahfoud","year":"2014","unstructured":"Mahfoud, F. et al. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial. Eur Heart J 35, 2224\u20132231b, doi: 10.1093\/eurheartj\/ehu093 (2014).","journal-title":"Eur Heart J"},{"key":"BFsrep38447_CR36","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/j.jacc.2012.05.036","volume":"60","author":"E Pokushalov","year":"2012","unstructured":"Pokushalov, E. et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 60, 1163\u20131170, doi: 10.1016\/j.jacc.2012.05.036 (2012).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep38447_CR37","doi-asserted-by":"crossref","unstructured":"Polhemus, D. J. et al. Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling. Circ Res, doi: 10.1161\/CIRCRESAHA.115.308278 (2016).","DOI":"10.1161\/CIRCRESAHA.115.308278"},{"key":"BFsrep38447_CR38","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt, D. L. et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370, 1393\u20131401, doi: 10.1056\/NEJMoa1402670 (2014).","journal-title":"N Engl J Med"},{"key":"BFsrep38447_CR39","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1113\/jphysiol.2014.273078","volume":"592","author":"S Lekawanvijit","year":"2014","unstructured":"Lekawanvijit, S. & Krum, H. Cardiorenal syndrome: acute kidney injury secondary to cardiovascular disease and role of protein-bound uraemic toxins. J Physiol 592, 3969\u20133983, doi: 10.1113\/jphysiol.2014.273078 (2014).","journal-title":"J Physiol"},{"key":"BFsrep38447_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5301\/JN.2010.2030","volume":"24","author":"G Cerasola","year":"2011","unstructured":"Cerasola, G., Nardi, E., Palermo, A., Mule, G. & Cottone, S. Epidemiology and pathophysiology of left ventricular abnormalities in chronic kidney disease: a review. J Nephrol 24, 1\u201310 (2011).","journal-title":"J Nephrol"},{"key":"BFsrep38447_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.kint.2015.10.002","volume":"89","author":"IC Macdougall","year":"2016","unstructured":"Macdougall, I. C. et al. Iron management in chronic kidney disease: conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int 89, 28\u201339, doi: 10.1016\/j.kint.2015.10.002 (2016).","journal-title":"Kidney Int"},{"key":"BFsrep38447_CR42","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1681\/ASN.2011111078","volume":"23","author":"JL Babitt","year":"2012","unstructured":"Babitt, J. L. & Lin, H. Y. Mechanisms of anemia in CKD. J Am Soc Nephrol 23, 1631\u20131634, doi: 10.1681\/ASN.2011111078 (2012).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep38447_CR43","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1681\/ASN.2015101125","volume":"27","author":"GM Chertow","year":"2016","unstructured":"Chertow, G. M., Beddhu, S., Lewis, J. B., Toto, R. D. & Cheung, A. K. Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT. J Am Soc Nephrol 27, 40\u201343, doi: 10.1681\/ASN.2015101125 (2016).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep38447_CR44","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1681\/ASN.V9112089","volume":"9","author":"S Hahn","year":"1998","unstructured":"Hahn, S. et al. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alpha-tocopherol. J Am Soc Nephrol 9, 2089\u20132095 (1998).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep38447_CR45","first-page":"653","volume":"64","author":"ZZ Li","year":"2015","unstructured":"Li, Z. Z. et al. Renal sympathetic denervation improves cardiac dysfunction in rats with chronic pressure overload. Physiol Res 64, 653\u2013662 (2015).","journal-title":"Physiol Res"},{"key":"BFsrep38447_CR46","doi-asserted-by":"publisher","first-page":"9205","DOI":"10.1523\/JNEUROSCI.2491-06.2006","volume":"26","author":"A Shekhar","year":"2006","unstructured":"Shekhar, A. et al. Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus. J Neurosci 26, 9205\u20139215, doi: 10.1523\/JNEUROSCI.2491-06.2006 (2006).","journal-title":"J Neurosci"},{"key":"BFsrep38447_CR47","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/bph.12317","volume":"170","author":"WH Cheng","year":"2013","unstructured":"Cheng, W. H. et al. Simvastatin induces a central hypotensive effect via Ras-mediated signalling to cause eNOS up-regulation. Br J Pharmacol 170, 847\u2013858, doi: 10.1111\/bph.12317 (2013).","journal-title":"Br J Pharmacol"},{"key":"BFsrep38447_CR48","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1161\/01.HYP.35.6.1253","volume":"35","author":"WC Lo","year":"2000","unstructured":"Lo, W. C., Jan, C. R., Chiang, H. T. & Tseng, C. J. Modulatory effects of carbon monoxide on baroreflex activation in nucleus tractus solitarii of rats. Hypertension 35, 1253\u20131257 (2000).","journal-title":"Hypertension"},{"key":"BFsrep38447_CR49","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/CIRCRESAHA.109.208439","volume":"106","author":"WH Cheng","year":"2010","unstructured":"Cheng, W. H. et al. Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1\/2-RSK signaling pathway to modulate central control of blood pressure. Circ Res 106, 788\u2013795, doi: 10.1161\/CIRCRESAHA.109.208439 (2010).","journal-title":"Circ Res"},{"key":"BFsrep38447_CR50","doi-asserted-by":"publisher","first-page":"22846","DOI":"10.1074\/jbc.M212055200","volume":"278","author":"IL Jung","year":"2003","unstructured":"Jung, I. L. & Kim, I. G. Polyamines and glutamate decarboxylase-based acid resistance in Escherichia coli. J Biol Chem 278, 22846\u201322852, doi: 10.1074\/jbc.M212055200 (2003).","journal-title":"J Biol Chem"},{"key":"BFsrep38447_CR51","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1097\/CCM.0b013e3182771364","volume":"41","author":"WH Lu","year":"2013","unstructured":"Lu, W. H. et al. Hexamethonium reverses the lethal cardiopulmonary damages in a rat model of brainstem lesions mimicking fatal enterovirus 71 encephalitis. Critical care medicine 41, 1276\u20131285, doi: 10.1097\/CCM.0b013e3182771364 (2013).","journal-title":"Critical care medicine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep38447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38447","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38447.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:37:15Z","timestamp":1672879035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep38447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep38447"],"URL":"https:\/\/doi.org\/10.1038\/srep38447","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,5]]},"assertion":[{"value":"23 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38447"}}